A Figure. A: This patient exhibits a saddle-nose def ormity fo llowing primary septorhinoplasty. B: Six months later; her profile is improved aft er injection of 1.3 in! of Radiesse.
Rhin oplasty is arguably one of the most difficult procedures to perform in plastic surgery. Subtle defe cts of only a few millimeters can mean the difference between a satisfied and unsatisfied patient. In some cases, nasal defects can be addre ssed by revision surgery ; revi sion rates are estimated to range fro m 4 to 7%, alth ough revisions are probably great ly underreported .' Yet nasal revision surgery has potential drawbacks. For example, it can increase the risk of nasal collap se or worsenin g of the deformity. Moreo ver, many patients may not be good cand idate s for surgical revision for financial, physical, or psychological reasons. For these patient s, minor contour irregularities may be addresse d and effe ctively impro ved with an office-based injectable impl ant.
Several injectable fillers have been used for augmenting nasal defects. Hyalur onic acids and co llage n are well accepted by physicians and patients alike, but the expect ed correction lasts only days to weeks. ' Silicone has been reported to be very successful in perm anently filling and co rrecting nasal defects, but there is always the risk of a long-term co mplication such as gra nuloma formati on or a persistent foreign-b ody reaction.v' Also, in view of FACIAL PLASTIC SURG ERY CLINIC silico ne's permanen t nature, its presen ce may make any future revision surge ry ext remely difficult.
Radiesse is a lon g-lastin g impl ant material that has been approved by the federal Food and Dru g Adm inistrati on (FDA) for the treatm ent of ora l and ma xillofacial defects, for vocal fold aug me ntatio n, for rad iographic tissue marking, and for other indications that are under review.' Th e co mpo und is made up of ca lcium hydro xylap atite particles suspended in a carb oxyme thylcellulose ge l. It is a sterile prod uct that is injec ted directly into the desired area . Although Rad iesse is not appro ved by the FDA for the augment ation of facial soft tissues, it is co mmo nly used off-label to co rrect age-related facial defor mities such as wrinkles , folds, and other depressions."
One of the man y adva ntages of Rad iesse is its dur ab ility. It has been reported to be effec tive for up to 18 mo nth s in facial soft tissues. Injection s with Radiesse have been associated with high patient sa tisfac tion, littl e downt ime, ENT3.6F Nasopharyngoscope and a low risk of compl ications.F Th e most co mmo nly reported side effec ts-mild brui sin g, nod ularit y, and ove rco rrection-are tem porary.' Within the past 2 years, we have used Radiesse to treat 8 patient s who had nasal defect s ( figure) . We have ex perienced high patien t satisfaction and long-lasting results with Radiesse injection s for minornasal defect s, esp ecially those that involve the bon y dorsum or rad ix, Persistent con vexity of the dorsum can be camoufla ged wi th the imp lant placed into the radix and into the supratip area.
Each of our patie nts recei ved between 0.3 and 1.6 ml of Rad iesse. A 27-gau ge needl e was used to inject the impl ant into the subcutaneo us tissues or into a subpe rios teal plane at the nasal defect. T he mate rial wa s then massaged and shaped into place. O nly a topical anesthetic was nec essary, and patie nts reported mini mal discomfort. Im provement was im mediate, and patie nts were disc harged from the office within minutes of the co mpletion of the pro cedur e. Brui sing and swe lling we re min imal. Pati ent and ph ysician sa tisfaction with the result lasted approximately I year, and we have obse rved no significa nt adv ers e events.
We have also performed rhi noplasty revision surge ry on a patient who had received 0.6 ml of Rad iesse 14 mo nths ear lier. Her surge ry was performed uneventfully and withou t unantici pated difficulty. No residu al implant ma ter ial was noted , nor were there any significa nt cha nges in the skin/soft-tiss ue envelope to compromise surg ica l techn iques.
Many patients today de sire rap id office-bas ed solutions to their problem s. Injection with Rad iesse is a potential option for improvin g the appearance of bony nasal defects and contour irreg ularities in some patient s. It can be injected witho ut significant concern abou t lon g-l asting complications and wit hout compromising future surgica l revision. W hile surge ry is the optima l cho ice for improving nasal defects, Radiesse is a possibi lity fo r those fo r who m this is not practical.
